Blood Flow Measurement Devices Market Size, Share, Industry, Forecast and outlook (2026-2033)

Blood Flow Measurement Devices Market is segmented By Device Type (Ultrasound Devices (Ultrasound Doppler, Transit-Time Flow Meters), Laser Doppler, Electromagnetic Blood Flowmeters, Plethysmography Chamber Flow meter), By Application (CABG, Microvascular Surgery, Others), and Non-Invasive Applications (Diabetes, Cardiovascular Disease, Tumor Monitoring, Gastroenterology, Others), By End-Users(Hospitals, Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2026-2033

Last Updated: || Author: Akshay Reddy || Reviewed: Akshay Reddy || SKU: MD1617

Buy any syndicated report and get free complimentary customization of up to 20% of the Report and an interactive dashboard.

Free Dashboard
Report Summary
Table of Contents
List of Tables & Figures

Blood Flow Measurement Devices Market Size

The global blood flow measurement devices market reached US$ 1.68 billion in 2025 and is expected to reach US$ 2.76 billion by 2033, growing at a CAGR of 6.8% during the forecast period from 2026 to 2033.

The market is witnessing steady growth driven by the increasing prevalence of cardiovascular diseases, peripheral vascular disorders, and diabetes related circulatory complications worldwide. Rising demand for minimally invasive diagnostic procedures, growing adoption of Doppler ultrasound systems, laser Doppler flowmetry devices, and transit time flow measurement technologies are significantly supporting market expansion. In addition, increasing surgical volumes, expanding use of blood flow monitoring in neurology and oncology applications, and technological advancements in non invasive vascular assessment systems are further contributing to market growth globally.

Blood flow measurement devices are designed to access and quantify blood flow within the human body. These devices play a crucial role in various medical specialties including cardiology, vascular surgery, and neurology.

Blood flow meters are used to monitor the blood flow in various blood vessels and to measure cardiac output. Ultrasound doppler, transit-time flow meters, electromagnetic blood flowmeters, and plethysmography chamber flow meters are the commonly used blood flow measurement devices.

Blood Flow Measurement Devices Market Scope

MetricsDetails
CAGR6.8%
Market Size Available for Years2023-2033
Market Estimation Forecast Period2026-2033
Revenue UnitsValue (US$ Mn) 
Segments CoveredDevice Type, Application, End Users
Regions CoveredNorth America, Europe, Asia-Pacific, South America, and Middle East & Africa
Largest RegionNorth America
Fastest Growing RegionAsia-Pacific
Report Insights CoveredCompetitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.

 

For more details on this report Request for Sample

Blood Flow Measurement Devices Market Dynamics

Increasing product launches 

The increasing number of product launches for foot blood flow measurement devices acts as a significant driver for market growth. Also, many significant companies play a major role in the advancements of the market by launching new blood flow measurement devices.

For instance, in June 2023, Stat Health launched an in-ear wearable that measures blood flow. It is designed wearable to help understand symptoms like dizziness, brain fog, headaches, fainting, and fatigue.

Additionally, in April 2021, NovaSignal Corp. launched the NovaGuide 2 Intelligent Ultrasound which autonomously measures the blood flow to identify brain illnesses and diseases.

Furthermore, the global blood flow measurement market is driven by various factors like the rising prevalence of cardiovascular diseases, technological advancements, and a rise in demand for blood flow measurement devices are expected to drive the market in the forecast period.

Stringent regulatory approvals

Stringent regulatory approvals for blood flow measurement devices can hamper the market growth as they involve rigorous testing and evaluation of the device to ensure specific standards for accuracy, reliability, and safety.

Blood Flow Measurement Devices Market Segment Analysis

The global blood flow measurement market is segmented based on device type, application, end users and region.

Ultrasound devices accounted for approximately 38.9% of the market share 

Doppler ultrasound is a noninvasive test that can be used to estimate the blood flow through the blood vessels by bouncing high-frequency sound waves. Ultrasound devices are expected to hold the largest market share over the period forecast owing to increasing new standard device launches and technological advancements. 

For instance, in February 2022, Philips expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities for real-time blood flow on its handheld point-of-care ultrasound called Lumify.

Additionally, in August 2021, Trivitron launched SonoRad V60 Ultrasound. The device is equipped with innovative color flow technology that improves blood flow measurement and visualization and offers a 3D-like flow impression.

Blood Flow Measurement Devices Market Geographical Share

North America is expected to hold a significant position in the global blood flow measurement devices market share

The global blood flow measurement devices market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa. 

North America has maintained a significant market proportion due to factors such as the rising prevalence of cardiovascular disorders, and product launches, this trend is anticipated to continue throughout the forecast period.

For instance, according to the Centers for Disease Control and Prevention 2023 report, in the United States, heart disease is the top cause of death for both men and women. In the US, an estimated 805,000 people suffer a heart attack annually. Hence, the requirement for blood flow measurement devices increases due to the rising prevalence of cardiovascular diseases.

Additionally, in April 2023, GE HealthCare launched its next-generation intraoperative ultrasound called bkActiv system. It features a sensitive color Doppler to visualize and measure the speed and direction of blood flow during complex surgical procedures.

Blood Flow Measurement Devices Market Companies

The major global players in the market include Cook Medical Inc., Medistim ASA, Transonic Systems, Inc., Deltex Medical Group PLC, Biopac Systems Inc., ATYS Medical, Perimed AB, ADInstruments, Getinge AB, Compumedics Limited among others.

Key Developments in the Blood Flow Measurement Devices Market

  • September 2026: The blood flow measurement devices market continued expanding, with demand supported by cardiovascular disease prevalence, minimally invasive diagnostics and advanced hemodynamic monitoring technologies.
  • August 2026: Medistim continued strengthening its position in transit-time flow measurement (TTFM) and high-frequency ultrasound technologies for intraoperative assessment of blood flow, particularly in coronary and peripheral vascular surgery.
  • August 2026: Research activity increasingly focused on combining ultrasound localization microscopy and photoacoustic imaging to provide simultaneous information on microvascular perfusion and blood oxygenation, highlighting the potential direction of next-generation flow-monitoring technologies.
  • July 2026: The European blood flow measurement devices market continued to expand, supported by advanced hospital infrastructure, adoption of non-invasive diagnostic technologies and increasing clinical and research applications.
  • July 2026: Perimed and other specialist manufacturers continued focusing on laser Doppler technologies for measuring microcirculation and tissue perfusion, an area expected to remain important as demand for non-invasive vascular assessment increases.
  • June 2026: Medistim, Transonic and Getinge remained important competitors in intraoperative flow verification and hemodynamic monitoring, with market development increasingly centered on measurement accuracy, workflow integration and clinical evidence.
  • May 2026: The global market continued moving toward AI-integrated measurement platforms, portable flow-assessment devices and greater integration with surgical workflows, creating opportunities for companies including Cook Medical, Deltex Medical, Compumedics and Biopac Systems.
  • May 2026: Growing demand for non-invasive vascular assessment and continuous hemodynamic monitoring continued supporting adoption of Doppler ultrasound, laser Doppler, electromagnetic and other blood-flow measurement technologies.
  • April 2026: Ultrasound Doppler technologies remained a major product segment, while laser Doppler systems continued gaining attention for microvascular and tissue-perfusion applications

Why Purchase the Report?

  • To visualize the global blood flow measurement devices market segmentation based on device type, application, end users and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of blood flow measurement devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global blood flow measurement devices market report would provide approximately 61 tables, 58 figures, and 185 Pages.

Target Audience 

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Save 31% on all licenses
Single User$4350$2999Multi User$4850$3344Corporate$7850$5412

Free 20% customization + dashboard

Trusted by Global Leaders

ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
FAQ’s

  • Ultrasound devices Segment accounted for approximately 38.9% of the market share

  • Cook Medical Inc., Medistim ASA, Transonic Systems, Inc., Deltex Medical Group PLC, Biopac Systems Inc., ATYS Medical, Perimed AB, ADInstruments, Getinge AB, Compumedics Limited among others.

  • The global Blood Flow Measurement Devices Market reached US$1.68 billion in 2025 and The market is projected to reach US$2.76 billion by 2033 with a CAGR of 6.8%

  • Growing cardiovascular disease prevalence, increasing surgical procedures, demand for minimally invasive diagnostics, and advances in noninvasive blood-flow monitoring are creating sustained investment opportunities.

  • Key drivers include cardiovascular and peripheral vascular disorders, diabetes-related circulatory complications, technological advancements, rising surgical volumes, and growing adoption of Doppler and transit-time flow measurement technologies.

  • North America is the largest regional market, supported by high cardiovascular disease prevalence, advanced healthcare infrastructure, and continued product development.

  • Asia-Pacific is the fastest-growing region, supported by expanding healthcare infrastructure, increasing disease burden, rising surgical volumes, and adoption of advanced diagnostic technologies.

  • Investors should evaluate device accuracy, noninvasive capabilities, AI integration, portability, real-time monitoring, clinical validation, regulatory approvals, product launches, hospital partnerships, and geographic expansion.
What Our Clients Say About this Report
Gregory Ashford
Vice President of Medical Device Strategy
12 Mar, 2026
5/5
The Blood Flow Measurement Devices Market report provided a comprehensive assessment of an important and rapidly evolving medical device segment. The detailed coverage of ultrasound Doppler, transit-time flow meters, laser Doppler, electromagnetic flowmeters, and plethysmography technologies was particularly useful for understanding the competitive landscape. The application analysis across cardiovascular, vascular surgery, neurology, and other clinical areas also provided valuable direction for our strategic planning.
Marcus Fairchild
Chief Strategy Officer, Medical Diagnostics
23 Jun, 2026
5/5
A highly informative report with strong coverage of both established and emerging blood flow measurement technologies. The analysis of ultrasound devices and their expanding role in real-time blood flow visualization was particularly relevant to our technology strategy. The regional assessment, competitive benchmarking, and coverage of product launches and industry developments helped us evaluate market positioning and potential expansion opportunities more effectively.
PDF
DataM
Blood Flow Measurement Devices Market Report
SKU: MD1617

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports